Stock UG UNITED-GUARDIAN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company United-Guardian, Inc.

Equities

UG

US9105711082

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
8.27 USD -1.24% Intraday chart for United-Guardian, Inc. +3.25% +14.86%
Mar. 22 United-Guardian, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 22 United-Guardian, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

United-Guardian, Inc. is engaged in manufacturing and marketing cosmetic ingredients, pharmaceutical products, medical lubricants and sexual wellness ingredients. Cosmetic ingredients include a line of multifunctional hydrogel formulations designed to offer sensory enhancement, lubrication, texture and moisturization to personal care products. Its cosmetic ingredients include Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural and Lubrajel Terra. Medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. Pharmaceutical products include an FDA approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial. Sexual wellness ingredients include a line of hydrogel formulations designed to offer sensory enhancement, lubrication and moisturization to sexual wellness applications.

Number of employees: 24

Sales per Business

USD in Million2022Weight2023Weight Delta
Pharmaceuticals
45.5 %
5 38.9 % 5 45.5 % +0.14%
Cosmetic Ingredients
38.0 %
5 40.7 % 4 38.0 % -20.04%
Medical Lubricants
16.1 %
2 19.5 % 2 16.1 % -29.13%
Industrial and Other
0.5 %
0 0.9 % 0 0.5 % -55.84%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
79.0 %
10 75.1 % 9 79.0 % -9.81%
Other Countries
21.0 %
3 24.9 % 2 21.0 % -27.75%

Managers

Managers TitleAgeSince
Donna Vigilante PSD
 President 44 -
Andrea J. Young DFI
 Director of Finance/CFO 55 16-08-31
Kenneth H. Globus CHM
 Chairman 72 83-12-31
Peter A. Hiltunen PRN
 Corporate Officer/Principal 65 02-06-30

Members of the board

Members of the board TitleAgeSince
Andrew A. Boccone BRD
 Director/Board Member 78 01-12-31
Arthur M. Dresner BRD
 Director/Board Member 82 96-12-31
Lawrence F. Maietta BRD
 Director/Board Member 66 93-12-31
Kenneth H. Globus CHM
 Chairman 72 83-12-31
S. Ari Papoulias BRD
 Director/Board Member 70 16-03-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,594,319 2,922,641 ( 63.61 %) 0 63.61 %

Shareholders

NameEquities%Valuation
Kenneth H. Globus
28.69 %
1,318,053 28.69 % 10 M $
Betsee Parker
7.338 %
337,128 7.338 % 3 M $
Renaissance Technologies LLC
4.000 %
183,763 4.000 % 1 M $
GAMCO Asset Management, Inc.
3.396 %
156,000 3.396 % 1 M $
Vanguard Global Advisers LLC
2.900 %
133,245 2.900 % 1 M $
Gabelli Funds LLC
2.302 %
105,761 2.302 % 809 072 $
Rodgers Brothers, Inc.
2.076 %
95,350 2.076 % 729 428 $
Dimensional Fund Advisors LP
1.853 %
85,138 1.853 % 651 306 $
Parthenon LLC
1.154 %
53,009 1.154 % 405 519 $
LB Hercules Holdings LLC
1.142 %
52,476 1.142 % 401 441 $

Company contact information

United-Guardian, Inc.

230 Marcus Boulevard

11788-3731, Hauppauge

+

http://www.u-g.com
address United-Guardian, Inc.(UG)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
UNITED-GUARDIAN, INC. Stock United-Guardian, Inc.
+14.86% 38M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.16% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.64% 231B
NOVARTIS AG Stock Novartis AG
+5.33% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.00% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. UG Stock
  4. Company United-Guardian, Inc.